We are live on ! Find out more
NVAX icon

Novavax

151 hedge funds and large institutions have $327M invested in Novavax in 2018 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 16

108% more capital invested

Capital invested by funds: $157M → $327M (+$170M)

24% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 38

21% more call options, than puts

Call options by funds: $4.3M | Put options by funds: $3.54M

13% more funds holding

Funds holding: 134151 (+17)

0.24% more ownership

Funds ownership: 2.02%2.26% (+0.24%)

Holders
151
Holders Change
+17
Holders Change %
+12.69%
% of All Funds
3.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
34
Increased
47
Reduced
38
Closed
16
Calls
$4.3M
Puts
$3.54M
Net Calls
+$761K
Net Calls Change
+$518K

NVAX Hedge Fund Activity: Q1 2018 in Review

151 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2018, worth a combined $327M — up 108% from $157M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NVAX positions and 16 closed out — a net gain of 18 holders — while 47 added to existing stakes and 38 trimmed.

The largest buyer was State Street, adding an estimated $26.4M. The largest seller was Citadel Advisors, cutting an estimated $2.58M.

  • 151 institutional investors held Novavax (NVAX) as of Q1 2018, up from 134 in Q4 2017.
  • Funds reported $327M of Novavax stock for Q1 2018, up 108% quarter-over-quarter.
  • 34 funds opened new Novavax positions in Q1 2018 and 16 closed out, a net change of +18 holders.
  • The largest Novavax buyer in Q1 2018 was State Street, an estimated $26.4M added.
  • The largest Novavax seller in Q1 2018 was Citadel Advisors, an estimated $2.58M sold.

Based on aggregated 13F filings for Q1 2018.